首页 › 脂肪性肝病 › 得克萨斯州 › San Antonio
San Antonio TX 脂肪性肝病临床试验
17项针对 脂肪性肝病的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 以及另外 2 项
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
招募中2 期
- American Research Corporation at The Texas Liver Institute, San Antonio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
招募中2 期
- American Research Corporation at The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research - San Antonio, San Antonio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
招募中3 期
- American Research Corporation at Texas Liver Institute, San Antonio
- Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
- IMA Clinical Research San Antonio, San Antonio
- 以及另外 1 项
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
招募中3 期
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- 以及另外 2 项
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中2 期
- Quality Research, Inc., San Antonio
- Pinnacle Clinical Research - South San Antonio, San Antonio
- Pinnacle Clinical Research, San Antonio
Quantifying Hepatic Mitochondrial Fluxes in Humans
招募中4 期
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
招募中2 期
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
招募中2 期
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
招募中1 期
- GSK Investigational Site, San Antonio
Evaluating the Pharmacokinetics and Safety of Miricorilant
招募中1 期
- Site# 433, San Antonio
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
招募中观察性研究
- Endeavor Clinical Trials, San Antonio
其他城市的 脂肪性肝病试验
- Miami, FL16 项研究
- New York City, NY16 项研究
- San Diego, CA14 项研究
- Austin, TX13 项研究
- Houston, TX13 项研究
- Richmond, VA12 项研究
- Tucson, AZ10 项研究
- Chandler, AZ10 项研究
- Hialeah, FL9 项研究
- Orlando, FL9 项研究
- Dallas, TX9 项研究
- St. Louis, MO9 项研究
San Antonio的其他研究
- 非小细胞肺癌59 项研究
- 乳腺癌47 项研究
- 结直肠癌46 项研究
- 转移性癌症44 项研究
- 癌症（所有类型）41 项研究
- 肥胖症40 项研究
- 2型糖尿病37 项研究
- 超重34 项研究
- 卵巢癌31 项研究
- 胰腺癌31 项研究
- 前列腺癌28 项研究
- 子宫内膜癌27 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。